Britain appoints vaccines minister | Guardian News | Nambucca Heads, NSW - Nambucca Guardian News

The British government has appointed a vaccines minister as it prepares to inoculate millions of people against the coronavirus, potentially starting within days. Prime Minister Boris Johnson said Conservative MP Nadhim Zahawi will oversee the country's biggest vaccine program in decades. The UK medicines regulator is currently assessing two vaccines - one developed by Pfizer and BioNTech, the other by Oxford University and AstraZeneca - to see if they are safe and effective. The Guardian newspaper reported that hospitals have been told they could receive the first doses of the Pfizer shot the week of December 7, if it receives approval. The UK says frontline health care workers and nursing home residents will be the first to be vaccinated, followed by older people, starting with those over age 80. Britain has ordered 40 million doses of the Pfizer/BioNTech vaccine, enough for 20 million people, and 100 million doses of the Oxford/AstraZeneca vaccine. In all, the UK government has agreed to purchase up to 355 million doses of vaccine from seven different producers, as it prepares to vaccinate as many of the country's 67 million people as possible. Pfizer and BioNTech say their vaccine is 95 per cent effective, according to preliminary data. It must be stored at ultra-cold temperatures of around minus 70C. The Oxford-AstraZeneca vaccine can be stored at conventional refrigerator temperatures, and is also cheaper than its main rivals. But some scientists have questioned gaps in its reported results. Oxford and AstraZeneca reported this week that their vaccine appeared to be 62 per cent effective in people who received two doses, and 90 per cent effective when volunteers were given a half dose followed by a full dose. They said the half dose was administered because of a manufacturing error, and they plan a new clinical trial to investigate the most effective dosing regimen. Britain has had Europe's deadliest COVID-19 outbreak, with more than 57,000 confirmed virus-related deaths. The prime minister said this week that officials hope to inoculate "the vast majority of the people who need the most protection by Easter". But he warned that "we must first navigate a hard winter" of restrictions. A four-week national lockdown in England is due to end on Wednesday, and will be replaced by three-tiered system of regional measures that restrict business activity, travel and socialising. Australian Associated Press

The British government has appointed a vaccines minister as it prepares to inoculate millions of people against the coronavirus, potentially starting within days.

Prime Minister Boris Johnson said Conservative MP Nadhim Zahawi will oversee the country's biggest vaccine program in decades.

The UK medicines regulator is currently assessing two vaccines - one developed by Pfizer and BioNTech, the other by Oxford University and AstraZeneca - to see if they are safe and effective.

The Guardian newspaper reported that hospitals have been told they could receive the first doses of the Pfizer shot the week of December 7, if it receives approval.

The UK says frontline health care workers and nursing home residents will be the first to be vaccinated, followed by older people, starting with those over age 80.

Britain has ordered 40 million doses of the Pfizer/BioNTech vaccine, enough for 20 million people, and 100 million doses of the Oxford/AstraZeneca vaccine.

In all, the UK government has agreed to purchase up to 355 million doses of vaccine from seven different producers, as it prepares to vaccinate as many of the country's 67 million people as possible.

Pfizer and BioNTech say their vaccine is 95 per cent effective, according to preliminary data.

It must be stored at ultra-cold temperatures of around minus 70C.

The Oxford-AstraZeneca vaccine can be stored at conventional refrigerator temperatures, and is also cheaper than its main rivals. But some scientists have questioned gaps in its reported results.

Oxford and AstraZeneca reported this week that their vaccine appeared to be 62 per cent effective in people who received two doses, and 90 per cent effective when volunteers were given a half dose followed by a full dose.

They said the half dose was administered because of a manufacturing error, and they plan a new clinical trial to investigate the most effective dosing regimen.

Britain has had Europe's deadliest COVID-19 outbreak, with more than 57,000 confirmed virus-related deaths.

The prime minister said this week that officials hope to inoculate "the vast majority of the people who need the most protection by Easter".

But he warned that "we must first navigate a hard winter" of restrictions.

A four-week national lockdown in England is due to end on Wednesday, and will be replaced by three-tiered system of regional measures that restrict business activity, travel and socialising.

Australian Associated Press

Let's block ads! (Why?)

https://news.google.com/__i/rss/rd/articles/CBMiXmh0dHBzOi8vd3d3Lm5hbWJ1Y2NhZ3VhcmRpYW4uY29tLmF1L3N0b3J5LzcwMzI1NjIvYnJpdGFpbi1hcHBvaW50cy12YWNjaW5lcy1taW5pc3Rlci8_Y3M9MTA5NzDSAQA?oc=5

2020-11-28 13:38:25Z
52781212664459

Bagikan Berita Ini